Clinically Evaluated
The Steadi-3 Plus has been evaluated using established clinical assessments for tremor severity, including the Archimedes spiral test and the Fahn-Tolosa-Marin (FTM) tremor rating scale (both widely recognized in neurological research). These methods provide objective measurement of tremor reduction across functional tasks.
Demonstrated Reduction in Tremor Severity
In clinical evaluation, most participants experienced measurable improvements in tremor control when using the Steadi-3 Plus compared to both no intervention and placebo conditions. Improvements were observed across common daily activities, including drinking, reaching, and fine motor tasks.
Consistent Performance Across Daily Activities
Analysis showed that tremor reduction remained consistent across multiple task types, indicating that the Steadi-3 Plus delivers stable, reliable support in real-world scenarios and not just isolated or controlled conditions.
Designed for Functional Use, Not Passive Intervention
Unlike approaches that require dedicated sessions separate from daily life, the Steadi-3 Plus is designed to be worn during active tasks. This enables users to maintain independence and perform essential activities while receiving continuous stabilization.
High User Compliance and Continued Use
Participant feedback indicated strong user satisfaction, with the majority reporting meaningful improvement and a willingness to continue using the device as part of their daily routine. This reflects both functional benefit and ease of integration into everyday life.
Safe, Non-Invasive, and Drug-Free
The Steadi-3 Plus offers a non-invasive approach to tremor management, without the need for medication or electrical stimulation. Its battery-free design and FDA-registered status further support its safety profile for individuals managing essential or Parkinsonian tremors.